LifeStance Health Group (NASDAQ:LFST) Now Covered by Barclays

Barclays assumed coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research note issued to investors on Tuesday morning, MarketBeat reports. The brokerage issued an overweight rating and a $8.00 price objective on the stock.

LFST has been the topic of several other reports. UBS Group lifted their price objective on LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday, December 1st. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Wall Street Zen cut shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Finally, BTIG Research upped their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $8.86.

LifeStance Health Group Price Performance

LifeStance Health Group stock opened at $6.48 on Tuesday. The stock has a market capitalization of $2.52 billion, a P/E ratio of -216.00 and a beta of 1.13. The company’s fifty day moving average price is $5.76 and its 200 day moving average price is $5.31. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58. LifeStance Health Group has a 1 year low of $3.74 and a 1 year high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The business had revenue of $363.81 million for the quarter, compared to the consensus estimate of $355.06 million. During the same period last year, the firm posted ($0.02) earnings per share. The company’s revenue was up 16.3% compared to the same quarter last year. As a group, equities research analysts anticipate that LifeStance Health Group will post -0.18 earnings per share for the current fiscal year.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 57,240 shares of LifeStance Health Group stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider directly owned 261,292 shares of the company’s stock, valued at $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Several institutional investors have recently made changes to their positions in the company. Jacobs Levy Equity Management Inc. purchased a new stake in LifeStance Health Group in the first quarter valued at $7,932,000. Adage Capital Partners GP L.L.C. increased its position in shares of LifeStance Health Group by 43.8% during the first quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company’s stock valued at $1,532,000 after acquiring an additional 70,000 shares during the last quarter. TD Asset Management Inc purchased a new stake in LifeStance Health Group in the second quarter valued at approximately $780,000. Nuveen LLC purchased a new stake in shares of LifeStance Health Group in the 1st quarter valued at $6,928,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of LifeStance Health Group during the second quarter worth about $219,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.